Cancer Treatment Centers of America

We're available 24/7
(800) 615-3055

Chat online with us

Chat now

Other ways to contact us

Video
chat
Have us
call you
(800) 615-3055

Have questions? Call (800) 615-3055 to speak to a cancer information specialist.
Or we can call you.

The CTCA blog

Genomic tumor assessment offers more personalized treatment

CTCA

For more than 100 years, scientists have been searching for better ways to treat cancer. The development of an innovative diagnostic tool, called the genomic tumor assessment, represents a significant step forward for cancer patients.

Genomic tumor assessment, which is offered at CTCA, examines changes occurring within an individual patient’s tumor to identify treatment options not previously considered.

Blood test may help with colorectal cancer screening, early tests show

CTCA

Early tests are being done to research levels of a specific gene in the blood that may be linked to colorectal cancer. A study published in the Journal of the National Cancer Institute shows the findings.

Researchers in the gastrointestinal cancer research lab at Baylor Research Institute in Dallas screened several hundred patients to check for levels of miR-21 – a piece of DNA known as microRNA – in their blood. The patients either had colorectal polyps, which are non-cancerous, or colorectal cancer.

Scientists find gene linked to aggressive liver cancer

CTCA

An international team of scientists has identified a gene associated with aggressive liver cancer, which could lead to more targeted therapies. The finding also represents another step toward precision cancer treatment.

Led by National University of Singapore, the team found that patients with hepatocellular carcinoma express SALL4, a stem cell gene expressed in human fetuses but inactive in noncancerous adults.

Study follows childhood cancer survivors decades after treatment

CTCA

St. Jude Children’s Research Hospital has embarked on a major research study to investigate the long-term effects of cancer therapy on childhood survivors.

 “We have known for many years that adults who were treated for cancer in childhood have a higher risk for health problems, and these health problems appear to increase as they age,” said Dr. Melissa Hudson, principal investigator and Director of St. Jude’s Division of Cancer Survivorship.

Genes linked to breast and ovarian cancers can't be patented

CTCA

The Supreme Court’s ruling that human genes cannot be patented paves the way for new, more affordable tests for breast and ovarian cancer risk.

With a unanimous decision, the high court’s ruling on Thursday ended the almost 20-year monopoly Myriad Genetics held over testing for BRCA 1 and 2 genes. Mutations to either gene indicate a high risk for breast and ovarian cancers.

It takes a village

CTCA

When facing a cancer diagnosis and subsequent treatment, a strong support system is important.

In the summer issue of Cancer Fighters ThriveTM, Dale Lauer, acute myeloid leukemia patient, discusses how support can come in many forms and often from unlikely places.

Creative arts therapy benefits cancer patients, research says

CTCA

People with cancer who engage in creative arts therapy experience less depression and anxiety than those who don’t, according to a review of research trials conducted over 23 years.

A paper published in JAMA Internal Medicine analyzed 27 studies involving almost 1,600 people, some who were randomly assigned to participate in creative arts therapy such as music, art and dance.

Make an informed decision about prostate screening

CTCA

It’s Men’s Health Month, and prostate cancer is the second most common cancer among men.  In fact, there are over 2 million prostate cancer survivors currently living in the United States.

Early detection of prostate cancer enables doctors to identify prostate cancer in early stages when it may be easier to treat.

Your browser (Internet Explorer 7) is out of date. Learn how to update your browser.